期刊文献+

微小RNA-34a通过靶向CD44调节膀胱癌细胞J82周期 被引量:4

Micro RNA-34a regulates cell cycle by targeting CD44 in human bladder carcinoma cells
下载PDF
导出
摘要 目的观察微小RNA-34a(miR-34a)对膀胱癌细胞J82周期的影响,并探索其中的机制。方法于J82中转染miR-34a前体或miR-34a抑制物并验证转染效率,结合此前研究报道和生物信息学预测miR-34a的靶点,后通过荧光素酶报告实验验证miR-34a靶标基因CD44,通过Western blot和实时定量PCR方法检测CD44及其周期相关蛋白及信使RNA表达水平的变化,利用流式细胞仪检测膀胱癌细胞J82周期的变化。结果 miR-34a在膀胱癌细胞J82和组织中表达下调,转染miR-34a前体和抑制物后,获得满意的转染效果;双荧光素酶报告实验证实miR-34a对CD44的3'UTR活性显著调节,并伴随相关周期相关因子表达水平变化,同时观测到其对膀胱癌细胞J82周期的影响。miR-34a mimics明显降低膀胱癌细胞J82中CD44的表达,miR-34a inhibitor明显上调膀胱癌细胞J82中CD44的表达;CD44可以部分回复mir-34a对膀胱癌细胞J82周期的影响。结论微小RNA-34a通过直接靶向CD44调节膀胱癌细胞J82周期的变化。 Objective To investigate the role of microRNA-34a (miR-34a) in regulating the cell cycles of bladder cancer cell line J82 and explore the underlying mechanism. Methods J82 cells were transfected with a miR-34a mimic or an inhibitor to induce miR-34a overexpression or silencing. The RNA level of miR-34a in the transfected cells was detected by real-time PCR, and CD44 expressions at the mRNA and protein levels were detected by real-time PCR and Western blotting. Luciferase reporter assay was used to detect the activation of 3'UTR of CD44, and flow cytometry was performed to analyze the cell cycle changes. Results The expression level of miR-34a was significantly increased and CD44 expression significantly lowered in cells transfected with miR-34a mimic; miR-34a inhibitor transfection caused reverse effects on miR-34a and CD44 expressions. MiR-34a mimics downregulated while miR-34a inhibitor enhanced the activation of 3'UTR of CD44 with corresponding changes in the expressions of some cell cycle-related proteins. MiR-34a mimics and miR-34a inhibitor induced opposite changes in J82 cell cycle, which were partly reversed by CD44. Conclusion MiRNA-34a regulates cell cycles by targeting CD44 in human bladder carcinoma cell line J82.
出处 《南方医科大学学报》 CAS CSCD 北大核心 2015年第7期935-940,共6页 Journal of Southern Medical University
基金 澳门理工学院科研项目(RP/ESS-01/2013)
关键词 微小RNA-34a CD44 细胞周期 膀胱癌 微小RNA-34a miR-34a cell cycle bladder cancer
  • 相关文献

参考文献26

  • 1Schrader AJ, Sevinc S, Olbert PJ, et al. Gender-specificcharacteristics and survival of renal cell carcinoma [J]. Urologe A,2008,47(9): 1182.
  • 2Bukowski RM. Prognostic factors for survival in metastatic renalcell carcinoma update 2008[J]. Cancer, 2009, 115(10): 2273-81.
  • 3Fatica A, Fazi F. MicroRNA-Regulated pathways in hematologicalmalignancies: how to avoid cells playing out of tune [J]. Int J MolSci, 2013, 14(10): 20930-53.
  • 4Ling H, Fabbri M, Calin GA. MicroRNAs and other non-codingRNAs as targets for anticancer drug development[J]. Nat Rev DrugDiscov,2013, 12(11): 847-65.
  • 5He Y, Jiang X, Chen J. The role of miR-150 in normal andmalignant hematopoiesis[j]. Oncogene, 2014, 33(30): 3887-93.
  • 6Medimegh I,Omrane I,Privat M, et al. MicroRNAs expression intriple negative vs Non triple negative breast cancer in Tunisia:interaction with clinical outcome [J]. PLoS One, 2014, 9(11):elll877.
  • 7Corcoran C, Rani S, O'driscoll L. miR-34a is an intracellular andexosomal predictive biomarker for response to docetaxel withclinical relevance to prostate cancer progression[J].Prostate, 2014,74(13): 1320-34.
  • 8Yu GP, Zhong N, Chen GQ, et al. Downregulation of PEBP4, atarget of miR-34a, sensitizes drug-resistant lung cancer cells [J].Tumour Biol, 2014,35(10): 10341-9.
  • 9Li XJ, Ren ZJ, Tang JH. MicroRNA-34a: a potential therapeutictarget in human cancer[J]. Cell Death Dis, 2014, 5(8): el327.
  • 10Wu H, Huang M, Liu Y, et al. Luteolin induces apoptosis byup-regulating miR-34a in human gastric cancer cells [J]. TechnolCancer Res Treat, 2014(2): 11-13.

同被引文献53

  • 1Siegel R L, Miller K D,Jemal A. Cancer statistics, 2015[J]. CA Cancer J Clin,2015,65(1) :5-29.
  • 2Koh W J, Greer B E, Abu-Rustum N R, et al. Cervical Canc- er,Version 2. 2015[J]. J Natl Compr Cane Netw, 2015, 13 (4) :395-404.
  • 3Zhao Z J, Ren H Y, Yang F, et al. Expression, correlation, and prognostic value of TRAF2 and TRAF4 expression in malig: nant plural effusion cells in human breast eancer[J]. Diagn Cytopathol, 2015,43(11) :897-903.
  • 4Yang K,Wang F, Han J J. TRAF4 promotes the growth and invasion of colon cancer through the Wnt/β-eatenin pathway[J]. Int J Clin Exp Pathol,2015,8(2) :1419-1426.
  • 5Ren H Y, Wang J, Yang F, et al. Cytoplasmie TRAF4 contrib- utes to the activation of p70s6k signaling pathway in breast eaneer[J]. Oneotarget, 2015,6 (6) : 4080-4096.
  • 6Chapard C, Hohl D, Huber M. The TRAF-interaeting protein (TRAIP)is a novel E2F target with peak expression in mito- sis[J]. 0ncotarget,2015,6(25) :20933-20945.
  • 7Huang L, Liu Q, Zhang L, et al. Encephalomyoearditis virus 3C protease relieves TRAF family member-associated NF-κB activator(TANK)inhibitory effect on TRAF6-rnediated NF- κB signaling through cleavage of TANK[J]. J Biol Chem, 2015,290(46) :27618-27632.
  • 8Yang J, Wei D, Wang W, et al. TRAF4 enhances oral squa- mous cell carcinoma cell growth, invasion and migration by Wnt-β-eatenin signaling pathway[J]. Int J Clin Exp Pathol, 2015,8(9) :11837-11846.
  • 9Yao W,Wang X,Cai Q, et al. Knockdown of TRAF4 expres- sion suppresses osteosarcoma cell growth in vitro and in vivo [J]. Int J Mol Med,2014,34(6) :1655-1660.
  • 10Chen T,Gao F,Feng S,et al. MieroRNA-370 inhibits the pro- gression of non-small cell lung cancer by downregulating on- eogeneTRAF4[J]. Oneol Rep,2015,34(1) :461-468.

引证文献4

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部